Interim safety analysis of the DANTE trial: Perioperative atezolizumab   in combination with FLOT versus FLOT alone in patients with resectable   esophagogastric adenocarcinoma-A randomized, open-label phase II trial   of the German Gastric Group at the AIO and SAKK.

Document type:: Meeting Abstract
Author(s):: Homann, Nils; Lorenzen, Sylvie; Schenk, Michael; Thuss-Patience, Peter C.; Goekkurt, Eray; Hofheinz, Ralf Dieter; Kretzschmar, Albrecht; Bolling, Claus; Angermeier, Stefan; Wicki, Andreas; Siebenhuener, Alexander Rheinhard; Lindig, Udo; Pink, Daniel; Ettrich, Thomas Jens; Schmalenberg, Harald; Waberer, Lisa; Talbot, Jonathan; Pauligk, Claudia; Goetze, Thorsten Oliver; Al-Batran, Salah-Eddin
Title:: Interim safety analysis of the DANTE trial: Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma-A randomized, open-label phase II trial of the German Gastric Group at the AIO and SAKK.
Journal title abbreviation:: J Clin Oncol
Year:: 2020
Journal volume:: 38 Suppl S
Journal issue:: 15
Print-ISSN:: 0732-183X
TUM Institution:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Occurrences: